Share the Video:

Lessons from the cannabis industry

Steve DeAngelo, Amanda Reiman, Troy Dayton

Thirty-eight states and DC now permit medicinal or recreational marijuana use, giving rise to a $13b cannabis industry. Psychedelic entrepreneurs and activists are looking to this market for lessons. But while the cannabis and psychedelic markets share a similar outline— federal drug prohibition followed by and local and statewide reform initiatives—significant differences exist. Join us to explore what the budding psychedelic marketplace can learn from cannabis, as well as their critical differences.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Patents, commons, and innovation in psychedelic drug development

Universities and companies are claiming intellectual property on psychedelic compounds, sparking dialogue on how patents may impact innovation and access to care in the psychedelic ecosystem. Explore economic and cultural

Jonathan Sporn, Sisi Li, Graham Pechenik, Retsina Meyer, Anne Donohoe

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Psychedelic-AT Research and Science Social and Cultural

A Family Legacy: From a Mother to her Sons

Rick Doblin discusses growing up with the "queen of psychedelics", Rock and Cosmo's paths to this work, challenges of working with family, and their shared vision for the psychedelic renaissance.

Amanda Feilding, Rock Feilding-Mellen, Cosmo Fielding Mellen

PS2023 Cannabis Policy and Advocacy Psychedelic Science Public Benefit Research and Science Social and Cultural

Challenges and opportunities of psychedelic policy reform in Jamaica

Senator interview delves into policy reform complexities in Jamaica, addressing cannabis legacy and future of psychedelic retreat centers. Discussion explores challenges, opportunities, and pathways to progressive drug policies for a

Adriana Kertzer, Sen Sherene Golding Campbell

PS2023 Business Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research and Science

The evolving financial landscape for psychedelic medicine

Funding for psychedelic medicine is evolving, with a rise in commercial capital alongside philanthropic support. Balancing financial interests with equitable access and learning from scaling challenges are key considerations.

Henry Elkus

PS2023 Integration Psychedelic Assisted Therapy Psychedelic Science Research and Science Social and Cultural Spirituality

Judaism and Psychedelics

Panelists explore Judaism's historical, cultural, and contemporary views on psychedelics, examining their potential role in Jewish spirituality and healing practices through ritual, history, and mysticism. The conversation aims to deepen

Sam Shonkoff, Rabbi Tirzah Firestone, Madison Margolin

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Social and Cultural Social Justice

Wielding Power: The psychedelic ecosystem and the US federal government

Exploration of wielding power for global access to psychedelic healing in collaboration with the US government.

Lia Mix

PS2023 Policy Policy and Advocacy Psychedelic Science Research Research and Science Social and Cultural

Psychedelic policy approaches: from the visionary to the pragmatic

Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.

Tatiana Quintana, Melissa Lavasani, Logan Davidson

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Social and Cultural Spirituality

Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse

Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made

Robert Jesse, Michael Pollan

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social and Cultural

Psychedelic education today: kids, parents, and the public

Panel discusses equipping parents with youth drug use info, fostering open conversations, and addressing public perception. Transformative drug education empowers communities, dismantles stigma, and cultivates informed society.

Vilmarie Narloch, Rhana Hashemi, Stefanie Jones, Gina Giorgio

Lessons from the cannabis industry

Become a MAPS Member with a monthly donation

Related Videos